The content of this site is intended for U.S. residents. Please note that Nicola Wealth investment funds are generally not offered to U.S. residents at the present time. As such, the contents of this website should not be construed as an offer of any of Nicola Wealth’s investment funds to U.S. residents. Any information, statement or opinion set forth herein is general in nature, is not directed to or based on the financial situation or needs of any particular investor, and does not constitute, and should not be construed as, investment advice, forecast of future events, a guarantee of future results, or a recommendation with respect to any particular security or investment strategy or type of retirement account. Investors seeking financial advice regarding the appropriateness of investing in any securities or investment strategies should consult their financial professional.
Are you an accredited U.S. investor?
PostedApril 2, 2020
With hundreds of new COVID-19 cases everyday, will we ever find a solution? Host Ethan Astaneh speaks with Dr. Gary Wong and Dr. Rob Kozak about the process, challenges and journey to creating the COVID-19 vaccine.
Dr. Kozak is a Clinical Microbiologist working out of Sunnybrook in Toronto. It was his team that isolated the COVID-19 virus, making the vaccine possible. Dr. Wong is a Virologist and faculty member of Infectious Disease Research at the University of Laval. He’s currently in China where he traveled to work on the frontlines, running a testing centre near Hubei, while studying the virus.
Focused on COVID-19 now, both worked on the team that developed the Ebola vaccine and provide a unique perspective on creating a vaccine in the midst of a pandemic.
Sunnybrook Health Sciences Center
Dr. Wong is a Virologist and faculty member of Infectious Disease Research at the University of Laval. He’s currently in Shanghai, China where he traveled to work on the frontlines, running a testing centre near Hubei province, during the peak of the outbreak in China and is now focusing his efforts on the development of the COVID-19 vaccine.
He received his Ph.D. in Medical Microbiology from the University of Manitoba in 2014 and carried out his research with the Special Pathogens Program at the National Microbiology Laboratory (NML), Public Health Agency of Canada (PHAC).
Dr. Kozak is a Clinical Microbiologist with over 13 years of experience working within multi-disciplinary teams on Biosafety Level 2, 3, and 4 human pathogens in research and public health settings. His current research interests are in developing vaccines for viral zoonotic diseases, creating next-generation diagnostic assays, and optimizing oncolytic viruses for cancer therapy.
For his full bio, visit: LinkedIn/com/in/RobKozak1
Ethan is a Financial Advisor in the firm’s Vancouver office and is the host of the Wealth Exchange podcast’s Lead Impact and Market Commentary segments. He provides strategic advice to high net worth business owners, professionals, and retirees, and offers his clients a wide range of financial services, including; retirement income planning, business succession, and continuation planning, investment management, tax and estate planning, charitable giving, and intergenerational wealth transfer.
For his full bio, visit: nicolawealth.local/Our-Team/Ethan-Astaneh
This presentation contains the current opinions of the presenter and such opinions are subject to change without notice. This material is distributed for informational purposes only and is not intended to provide legal, accounting, tax or specific investment advice. Please speak to your NWM advisor regarding your unique situation. Forecasts, estimates, and certain information contained herein are based upon proprietary research and should not be considered as investment advice or a recommendation of any particular security, strategy or investment product. NWM Fund returns are quoted net of fund-level expenses. Past performance is not indicative of future results. All investments contain risk and may gain or lose value. Projected returns are estimates only. Returns are not guaranteed. NWM is registered as a Portfolio Manager, Exempt Market Dealer and Investment Fund Manager with the required provincial securities’ commissions in Canada.